Autoimmune Hemolytic Anemia
📧 Sign up to get email alerts when something new happens for Autoimmune Hemolytic Anemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-02-11Clinical Trial Update: PI3K Delta Inhibitor in Relapsed / Refractory Autoimmune Hemolytic Anemia Patients After Receiving Two or More Lines of Therapy [Phase 1]
A Phase 1 study of a PI3K delta inhibitor in relapsed or refractory autoimmune hemolytic anemia after two or more lines of therapy has been …
-
CLINICAL_TRIALS withdrawal · 2025-11-10Clinical Trial Update: Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated Cytopenias [Phase 2]
An extension study of fostamatinib (Syk inhibitor) for posttransplant immune-mediated cytopenias has been withdrawn, including autoimmune he…